{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid62zeikbqnfthucw33smbillkx5ik2hgqrhvenrotlep3cd2hwp4",
    "uri": "at://did:plc:vjq5h74saws2ps33jucrjhfb/app.bsky.feed.post/3mgwvn42s2lb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifurt2zmdimbir3tzl5k7lt5hm6khdur5uxmnaq2ikx6p4wfuua2m"
    },
    "mimeType": "image/png",
    "size": 2016715
  },
  "path": "/biontech-bntx-q4-2025-year-end-review/",
  "publishedAt": "2026-03-12T19:08:39.000Z",
  "site": "https://www.cestriancapitalresearch.com",
  "tags": [
    "All Inner Circle Notes",
    "Biotech"
  ],
  "textContent": "I Read the Chart, Not the News",
  "title": "BioNTech (BNTX) - Q4 2025 - Year End Review"
}